Combined laboratory and imaging indicators to construct risk models for predicting immunotherapy efficacy and prognosis in non-small cell lung cancer: An observational study (STROBE compliant).

This study evaluated pretreatment laboratory and imaging parameters to predict the short- and long-term efficacy of immu...

Continue ReadingCombined laboratory and imaging indicators to construct risk models for predicting immunotherapy efficacy and prognosis in non-small cell lung cancer: An observational study (STROBE compliant).